Bultink IEM - Search Results

1

Correction to: Management of glucocorticoid-induced osteoporosis.

Messina OD, Vidal LF, Wilman MV, Bultink IEM, Raterman HG, Lems W. Messina OD, et al. Among authors: bultink iem. Aging Clin Exp Res. 2022 Dec;34(12):3185. doi: 10.1007/s40520-021-01937-5. Epub 2021 Jul 23. Aging Clin Exp Res. 2022. PMID: 34297337 No abstract available.

2

Belimumab concentration measurements using a homologous anti-idiotype immunoassay.

Loeff FC, Parodis I, Walhelm T, Jönsen A, Nikolopoulos D, Sjöwall C, Bengtsson AA, Kos D, van Leeuwen A, van den Broek B, Dijk L, Jeremiasse J, Blomjous BS, Voskuyl AE, Wolbink GJ, Bultink IEM, Rispens T. Loeff FC, et al. Among authors: bultink iem. J Immunol Methods. 2024 Sep;532:113717. doi: 10.1016/j.jim.2024.113717. Epub 2024 Jul 2. J Immunol Methods. 2024. PMID: 38960066

3

Ferritin and serum transferrin receptor predict iron deficiency in anemic patients with rheumatoid arthritis.

Bultink IE, Lems WF, van de Stadt RJ, Dinant HJ, Leyte A, Park DS, de Koning MH, Dijkmans BA. Bultink IE, et al. Arthritis Rheum. 2001 Apr;44(4):979-81. doi: 10.1002/1529-0131(200104)44:4<979::AID-ANR157>3.0.CO;2-H. Arthritis Rheum. 2001. PMID: 11315939 Free article. No abstract available.

4

The effect of intravenous pamidronate versus oral alendronate on bone mineral density in patients with osteoporosis.

Vis M, Bultink IE, Dijkmans BA, Lems WF. Vis M, et al. Osteoporos Int. 2005 Nov;16(11):1432-5. doi: 10.1007/s00198-005-1862-z. Epub 2005 May 10. Osteoporos Int. 2005. PMID: 15883662

5

Prevention of glucocorticoid-induced osteoporosis.

van Brussel MS, Bultink IE, Lems WF. van Brussel MS, et al. Expert Opin Pharmacother. 2009 Apr;10(6):997-1005. doi: 10.1517/14656560902868225. Expert Opin Pharmacother. 2009. PMID: 19351276 Review.

6

Glucocorticoid-induced osteoporosis.

den Uyl D, Bultink IE, Lems WF. den Uyl D, et al. Clin Exp Rheumatol. 2011 Sep-Oct;29(5 Suppl 68):S93-8. Epub 2011 Oct 21. Clin Exp Rheumatol. 2011. PMID: 22018192 Review.

7

Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus.

Jacobs J, Korswagen LA, Schilder AM, van Tuyl LH, Dijkmans BA, Lems WF, Voskuyl AE, Bultink IE. Jacobs J, et al. Osteoporos Int. 2013 Jun;24(6):1827-33. doi: 10.1007/s00198-012-2157-9. Epub 2012 Oct 3. Osteoporos Int. 2013. PMID: 23052940

8

Optimizing fracture prevention: the fracture liaison service, an observational study.

Eekman DA, van Helden SH, Huisman AM, Verhaar HJ, Bultink IE, Geusens PP, Lips P, Lems WF. Eekman DA, et al. Osteoporos Int. 2014 Feb;25(2):701-9. doi: 10.1007/s00198-013-2481-8. Epub 2013 Sep 13. Osteoporos Int. 2014. PMID: 24030287

9

Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom.

Bultink IE, Harvey NC, Lalmohamed A, Cooper C, Lems WF, van Staa TP, de Vries F. Bultink IE, et al. Osteoporos Int. 2014 Apr;25(4):1275-83. doi: 10.1007/s00198-013-2587-z. Epub 2013 Dec 3. Osteoporos Int. 2014. PMID: 24297094

10

Making the invisible visible: bioelectrical impedance analysis demonstrates unfavourable body composition in rheumatoid arthritis patients in clinical practice.

Konijn NP, van Tuyl LH, Bultink IE, Lems WF, Earthman CP, van Bokhorst-de van der Schueren MA. Konijn NP, et al. Scand J Rheumatol. 2014;43(4):273-8. doi: 10.3109/03009742.2013.852239. Epub 2014 Feb 7. Scand J Rheumatol. 2014. PMID: 24797672

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters